Based on potential future earnings of $3 million a year, for sales of 3MT a year, the share price at 0.069c, for a market cap of only $1 million, looks ridicuosly cheap.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025